| abstract |
The invention relates to alkyl-containing 5-acylindolinones of the general formula (I), where R<1> to R<3> are as defined in claim 1, and to tautomers, enantiomers, diastereomers, mixtures and salts thereof with valuable pharmacological properties, more particularly an inhibitory effect on protein kinases, more particularly an inhibitory effect on the activity of glycogen synthase kinase (GSK-3). |